When you’ve tried treatment after treatment and still feel stuck in the same cycle of severe depression or anxiety, discovering an option that works differently and may offer relief much sooner can feel like a genuine turning point. Ketamine treatment is one of those options, offering a path that operates outside traditional antidepressant timelines.
So, how effective is ketamine therapy? In this article, we take a clear, research-driven look by focusing specifically on oral ketamine lozenges as offered by The Compassion Practice. We explore how ketamine compares across different approaches, including ketamine infusion, esketamine nasal spray, and oral formulations. We also review what clinical trial data, depression scores, remission rates, and open-label studies reveal about outcomes, dissociative effects, and overall safety.
The goal is to provide a balanced, human-centered perspective on what we know, areas that need more research, and what to keep in mind when using ketamine in a clinical setting, especially for treatment-resistant depression.
Key Takeaways
- Oral ketamine has shown promise in treating treatment-resistant depression, providing rapid relief, but its effects typically last only 1-2 weeks.
- Studies show that therapy during the treatment window helps integrate emotional insights and achieve lasting change.
- Personalized dosing is crucial to manage its variable bioavailability and side effects like dissociation or sedation.
What Is Ketamine Therapy — and What Is Oral Ketamine?
Originally developed as an anesthetic in the 1960s, ketamine has been repurposed since the early 2000s for treating resistant depression and other mood disorders (Source: Bloomberg School of Public Health). Ketamine works by affecting brain receptors, offering rapid relief, especially for those who haven’t found success with traditional treatments. Ketamine is commonly administered via intravenous (IV), nasal spray (like esketamine), or oral methods. While IV is the most studied, oral ketamine—in the form of dissolvable tablets or lozenges—provides greater convenience and accessibility outside of clinical settings (Source: Psychiatrist).
Ketamine-Assisted Psychotherapy (KAP) combines ketamine with therapy, enhancing emotional healing, particularly for those dealing with suicidal thoughts or substance use issues. In the case of oral ketamine, the lozenge is placed under the tongue or in the cheek for controlled, supervised use (Source: PMC). This method offers the same therapeutic benefits as intravenous treatments, with results often seen in 40 minutes.
In the context of ketamine therapy, a “lozenge” refers to a dissolvable tablet or sublingual form of ketamine that is placed under the tongue or inside the cheek for absorption. This method allows the medication to be absorbed into the bloodstream more gradually than intravenous administration. At The Compassion Practice, oral ketamine is administered under professional supervision to ensure proper dosing and safety during treatment.
What Does the Research Say: Ketamine’s Effectiveness in General
Rapid antidepressant and anxiolytic effects
Ketamine has shown promise in rapidly alleviating symptoms of depression and anxiety, often providing significant relief within hours of administration. Many patients experience a noticeable reduction in symptoms such as depression severity, suicidality, and anxiety, sometimes in cases where conventional treatments have been ineffective (Source: Psychiatry Online). These rapid antidepressant and anxiolytic effects are considered one of ketamine’s most distinctive features, differentiating it from traditional therapies that may take weeks to show results.
Effect duration & need for maintenance
However, the effects of a single dose of ketamine do not tend to last indefinitely. Research indicates that the antidepressant effects typically begin to diminish within 1 to 2 weeks following the initial dose (Source: PMC). This rapid fade in efficacy highlights the need for maintenance therapy to sustain the benefits. Meta-analyses and reviews of ketamine treatments suggest that repeated sessions, often paired with psychotherapy, can enhance the durability of its therapeutic effects. Regular treatments can help reinforce the initial improvements, potentially offering long-term benefits for individuals with treatment-resistant mental health conditions.
Oral Ketamine (Lozenges): What We Know and What’s Emerging
Clinical evidence supports that oral ketamine may offer some effectiveness for individuals with severe or treatment-resistant depression. Recent open-label and long-term (6-week) studies show promise for sustaining symptom improvements, particularly in conditions like PTSD, when used over time. The results are consistent with findings on the effectiveness of ketamine in treating depression. This treatment is being explored as an alternative when traditional methods fail (Source: PubMed).
However, there are key limitations and challenges specific to oral ketamine:
- Lower bioavailability: Only about 20–25% of the oral dose reaches the bloodstream, which requires careful dosing. This can impact the effectiveness of ketamine and may lead to a need for more frequent dosing. (Source: Psychiatrist)
- Variability: Individual differences in metabolism and absorption rates can affect how patients respond, making personalized dosing critical. This variability is especially important when managing potential sedation or dissociation effects. (Source: Frontiers)
- Less robust data: Compared to intravenous (IV) or nasal methods, there is less clinical evidence for oral ketamine, meaning more randomized studies are necessary to establish its safety and long-term efficacy in clinical settings. (Source: Cambridge)
What this means for patients:
- Convenience: Oral ketamine offers a more accessible option than intravenous or nasal methods, making it easier for patients to manage.
- Slower onset: The therapeutic effects may take longer to kick in due to slower absorption compared to other administration routes.
- Repeated dosing: For continued benefit, regular dosing or additional sessions may be required to maintain symptom relief.
- Therapy integration: Combining oral ketamine with psychotherapy is clinically shown to improve long-term outcomes and emotional healing, especially for those dealing with treatment-resistant conditions.
Why Combining Ketamine with Therapy Matters
- Ketamine may open a “window” of neuroplasticity — therapy during that window helps integrate insights, emotions, and behavioral change. Research suggests that ketamine can rapidly enhance the brain’s capacity to reorganize and form new neural connections (neuroplasticity), which may make the brain more receptive to psychotherapy. (Source: PMC)
- Studies show psychotherapy before, during, and after ketamine sessions can maximize and prolong benefits. For example, a recent review found that combining ketamine with structured therapy is associated with more durable improvements in mood and related symptoms than ketamine alone. (Source: MDPI)
- For oral ketamine lozenges (as used by The Compassion Practice), this integration can make the difference between short‑term relief and lasting growth. Oral forms tend to have slower onset and possibly shorter-lasting effects than more studied routes; integrating therapy helps anchor the benefits into long-term psychological change rather than merely transient symptom relief.
The Benefits for Patients
- Greater benefit: Using therapy during the neuroplastic window created by low-dose ketamine allows for deeper emotional processing and more lasting change, especially for treatment-resistant depression.
- More stable outcomes: Combining ketamine with therapy helps build coping strategies, address underlying issues, and reinforce healthier thinking patterns, leading to more sustained improvement in depression.
- Reduced risk of relapse: Therapy helps prevent a return to previous patterns once ketamine’s effects fade, stabilizing symptoms and reducing the risk of relapse.
- Personalized healing: Since responses to ketamine vary, therapy helps tailor the treatment to an individual’s unique mental health needs, promoting long-term healing.
What Conditions Ketamine Therapy Has Shown Promise For
Ketamine Therapy — Promising Conditions & Evidence Strength
|
Condition |
Evidence Strength |
Notes / Limitations |
|
Treatment‑Resistant Depression (TRD) |
Strong — multiple clinical trials and reviews show rapid antidepressant effects |
Considered among the most robust uses of ketamine, many patients show a significant reduction in depressive symptoms when other treatments fail. (SAGE Journals) |
|
Major Depressive Disorder (MDD) |
Strong / Moderate — effective especially when conventional treatments have failed |
Beneficial in both single-dose and repeated protocols for MDD, even without full resistance. (MDPI) |
|
Post‑Traumatic Stress Disorder (PTSD) / Trauma‑related disorders |
Emerging but promising — a growing number of studies showing benefit |
Particularly when combined with therapy, ketamine may help reduce PTSD symptoms and improve overall mental health outcomes. (PMC) |
|
Anxiety disorders / Generalized anxiety / Mood + Pain comorbidity / Chronic pain with mood component |
Preliminary / Limited — some supportive data but less consistent |
For patients with depression + pain or anxiety, ketamine sometimes improves mood and pain, but evidence is more mixed, and protocols vary. (Frontiers) |
Note: In all cases, benefits tend to be strongest and most reproducible when ketamine is administered under clinical supervision and often paired with ongoing mental‑health support or therapy.
Risks, Limitations & What Research Still Doesn’t Tell Us
- Short‑lived effects/relapse without maintenance → A maintenance‑treatment study reports that while ketamine has rapid antidepressant action, its effects often fade over time without follow‑up dosing or ongoing treatment. (University of Groningen Research)
- Safety, tolerability, and absorption variability with oral ketamine → A systematic review on oral ketamine concluded that only a small number of clinical studies exist, and that although tolerability appears acceptable, effects are slower than IV; this underscores both variability and limited data. (PubMed)
- Regulatory status (off‑label use, lack of regulatory approval for psychiatric use of compounded forms) → A recent editorial on professional regulation of ketamine use states that most ketamine prescriptions for psychiatric disorders remain off-label and not approved by regulators. (JAAAPL)
- Need for more high‑quality, long‑term studies (especially for oral ketamine + therapy) → A recent phase‑2 trial of extended‑release oral ketamine for treatment-resistant depression highlights that only a few of many RCTs (Randomized Control Trials) used oral dosing — signaling that robust long‑term data remain scarce. (nature.com)
What This Means for People Considering Oral Ketamine — Questions to Ask & How to Approach It
When considering oral ketamine, it’s crucial to assess whether you’ve already tried and not responded to conventional treatment options like antidepressants or therapy, especially if you have treatment-resistant depression. Unlike intravenous ketamine, oral ketamine may require repeated sessions, along with therapy integration, to maintain its effect on depression over time.
Ask about the dosing strategy, how therapy integration will work, and the follow-up plan, especially for low doses of ketamine. Remember that ketamine for depression is not a quick fix; it’s an investment in long-term well-being, aligning with The Compassion Practice’s client-centered philosophy. This treatment aims for sustained improvement in depression symptoms and treatment response, providing a comprehensive approach to mental health care beyond just symptom relief.
Common Questions About Ketamine Therapy
Is ketamine therapy legal and approved for depression or PTSD?
Ketamine therapy is legal in many countries, including the U.S., but its use for depression and PTSD is off-label, meaning it is not FDA-approved specifically for these conditions. It is used by licensed healthcare professionals in ketamine clinics, following established protocols for treatment.
How soon can I expect results with oral ketamine lozenges?
With oral ketamine lozenges, many patients experience initial effects within 40 minutes to an hour, though it may take several sessions to see full benefits. Results can vary depending on individual metabolism and treatment response.
How long do benefits last? Will I need ongoing treatments?
The effects of oral ketamine typically last for 1–2 weeks after a session, though this varies. Ongoing treatments or maintenance sessions are often necessary to maintain the benefits, particularly in treatment-resistant depression.
Is oral ketamine safe? What are the side effects?
Oral ketamine is generally safe when administered under clinical supervision, but potential side effects include sedation, dissociation, and increased blood pressure. The long-term safety of oral ketamine is still under study, and personalized dosing helps mitigate risks.
Is therapy required along with ketamine? Can you do lozenges alone?
While therapy is highly recommended to maximize the benefits of oral ketamine, it is not strictly required. Combining ketamine therapy with psychotherapy helps integrate emotional insights and leads to more lasting change.
What makes The Compassion Practice’s approach different?
The Compassion Practice emphasizes a holistic, client-centered approach, combining oral ketamine therapy with psychotherapy to promote long-term emotional healing. Our focus on personalized care, safety, and integrated mental health sets us apart from other clinics offering ketamine therapy.
Final Thoughts: Is Ketamine Therapy Right for You?
Low-dose ketamine therapy — especially when combined with psychotherapy — shows significant promise as a treatment for depression. While the effects of ketamine can provide rapid relief, especially for those who have not responded to traditional treatments, it’s important to remember that it’s not a magic bullet. Improvement in depressive symptoms may occur quickly, but long-term success often requires repeated sessions, and therapy integration can help sustain progress.
If you’re considering ketamine for treatment-resistant depression, take the time to understand the safety and effectiveness of the treatment, and ask questions about the process.
The Compassion Practice offers personalized care and expert guidance on whether oral ketamine combined with therapy could be right for you.
Contact us today to learn more, schedule a consultation, and discuss if this treatment is a good fit for your mental health goals.
